Cytoreductive surgery combined with HIPEC in newly diagnosed and recurrent ovarian cancer

Journal Title: European Journal of Gynaecological Oncology - Year 2019, Vol 40, Issue 1

Abstract

Objective: Perioperative intraperitoneal chemotherapy after cytoreductive surgery is used in ovarian cancer treatment. The purpose of the study is the evaluation of the effect of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) as upfront treatment in advanced ovarian cancer. Materials and Methods: Prospective observational study of 166 women that underwent 189 cytoreductive operations for advanced ovarian cancer and in 55 of them HIPEC was used as upfront treatment. Clinical indicators were correlated to morbidity, hospital mortality, survival, and recurrences. Results: HIPEC as upfront treatment was found to be related to recurrence (p = 0.001) but not to overall survival. The prognostic variables of survival were the performance status, the completeness of cytoreduction, and the use of HIPEC (p < 0.001). The prognostic variables of recurrence were the degree of differentiation, and systemic chemotherapy (p = 0.05). Conclusion: HIPEC as upfront treatment after cytoreductive surgery may be another promising treatment strategy in patients with epithelial ovarian cancer. Prospective randomized trials are required.

Authors and Affiliations

A. A. K. Tentes, T. B. Palaskas, K. Stamou, C. E. Stoforos, N. Pallas, C. Karamveri, D. Kyziridis, V. Kyriakopoulos

Keywords

Related Articles

Complementary and alternative medicine. Use and challenges among gynaecological cancer patients in Nigeria: experiences in a tertiary health institution - preliminary results

Background: Cancer patients have keyed into increasing global interest in the use of Complementary and Alternative Medicine (CAM). There are few studies on CAM use among gynaecological cancer patients in our environment....

Surgical management of recurrent gynecological cancer: Complete resection is the key to longer survival

Summary Purpose of investigation: This study was conducted to elucidate the efficacy and feasibility of surgical management of recurrent gynecological (cervical, endometrial, and ovarian) cancers. Materials and Methods:...

Diffusion magnetic resonance in cervical carcinoma: the role of apparent diffusion coefficient in the evaluation of treatment response

Purpose: The aim of the study was to determinate the role of apparent diffusion coefficient (ADC) in order to find cut-off values in the evaluation of treatment response. Materials and Methods: A retrospective study was...

Role of transvaginal ultrasound in finding endometrial cancer in postmenopausal women with or without bleeding

Purpose of Investigation: To determine the endometrial thickness (ET) threshold to predict high risk of endometrial cancer (EC) in symptomatic and asymptomatic postmenopausal patients. It is also assessed whether additio...

Survival rate and complications after different types of pelvic exenteration for gynecological cancer

Pelvic exenteration (PE) is an operative method for one-moment removal of pelvic organs, including reproductive tract, bladder, and rectosidgmoid. It is most commonly indicated in gynecologic oncology for treatment of lo...

Download PDF file
  • EP ID EP626319
  • DOI 10.12892/ejgo4248.2019
  • Views 77
  • Downloads 0

How To Cite

A. A. K. Tentes, T. B. Palaskas, K. Stamou, C. E. Stoforos, N. Pallas, C. Karamveri, D. Kyziridis, V. Kyriakopoulos (2019). Cytoreductive surgery combined with HIPEC in newly diagnosed and recurrent ovarian cancer. European Journal of Gynaecological Oncology, 40(1), 49-54. https://europub.co.uk/articles/-A-626319